Financials International Medical Center of Biomaterials Processing and Cryostorage Public
Equities
GEMA
RU000A100GC7
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
672 RUB | -0.22% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Capitalization 1 | 11,369 | 10,302 | 14,915 | 10,033 |
Enterprise Value (EV) 1 | 11,367 | 10,336 | 14,941 | 10,209 |
P/E ratio | 85.8 x | 83.9 x | 109 x | 102 x |
Yield | - | - | 0.87% | 1.19% |
Capitalization / Revenue | 47.7 x | 42.5 x | 56.1 x | 39.4 x |
EV / Revenue | 47.6 x | 42.6 x | 56.2 x | 40.1 x |
EV / EBITDA | 80.6 x | 69.7 x | 103 x | 71.8 x |
EV / FCF | 124 x | 108 x | -46 x | 18.3 x |
FCF Yield | 0.81% | 0.92% | -2.17% | 5.46% |
Price to Book | 57.9 x | 49.1 x | 74 x | 67.4 x |
Nbr of stocks (in thousands) | 14,930 | 14,930 | 14,930 | 14,930 |
Reference price 2 | 761.5 | 690.0 | 999.0 | 672.0 |
Announcement Date | 13/04/20 | 16/04/21 | 18/04/22 | 04/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 211.7 | 242.6 | 238.6 | 242.6 | 265.9 | 254.7 |
EBITDA 1 | 138.8 | 161.3 | 141 | 148.3 | 144.8 | 142.1 |
EBIT 1 | 133.7 | 155 | 137.4 | 141.9 | 140.3 | 138.3 |
Operating Margin | 63.15% | 63.88% | 57.6% | 58.47% | 52.77% | 54.31% |
Earnings before Tax (EBT) 1 | 131.6 | 141.8 | 119.3 | 122.8 | 136.5 | 98.17 |
Net income 1 | 131.6 | 141.8 | 119.3 | 122.8 | 136.5 | 98.17 |
Net margin | 62.19% | 58.43% | 49.98% | 50.6% | 51.34% | 38.55% |
EPS | - | 11.17 | 8.875 | 8.223 | 9.143 | 6.575 |
Free Cash Flow 1 | 38.55 | 121 | 91.87 | 95.29 | -324.6 | 557.6 |
FCF margin | 18.21% | 49.87% | 38.51% | 39.28% | -122.08% | 218.95% |
FCF Conversion (EBITDA) | 27.78% | 75.01% | 65.15% | 64.25% | - | 392.31% |
FCF Conversion (Net income) | 29.29% | 85.36% | 77.04% | 77.62% | - | 568.01% |
Dividend per Share | - | - | - | - | 8.650 | 8.022 |
Announcement Date | 21/01/19 | 25/06/19 | 13/04/20 | 16/04/21 | 18/04/22 | 04/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 34 | 25.7 | 176 |
Net Cash position 1 | 105 | 4.24 | 2.38 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | 0.2294 x | 0.1776 x | 1.242 x |
Free Cash Flow 1 | 38.5 | 121 | 91.9 | 95.3 | -325 | 558 |
ROE (net income / shareholders' equity) | 289% | 291% | 99.2% | 60.5% | 66.3% | 52.4% |
ROA (Net income/ Total Assets) | 37.9% | 31.7% | 19.2% | 14.6% | 13.2% | 10.9% |
Assets 1 | 347.5 | 446.5 | 620.9 | 842.3 | 1,036 | 898.6 |
Book Value Per Share | - | 3.480 | 13.10 | 14.10 | 13.50 | 9.960 |
Cash Flow per Share | - | 0.4400 | 2.320 | 1.690 | 2.410 | 5.090 |
Capex 1 | 0.23 | - | - | 2.46 | 4.72 | 9.27 |
Capex / Sales | 0.11% | - | - | 1.01% | 1.78% | 3.64% |
Announcement Date | 21/01/19 | 25/06/19 | 13/04/20 | 16/04/21 | 18/04/22 | 04/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 113M | |
+23.86% | 86.96B | |
-23.56% | 75.65B | |
+0.49% | 26.97B | |
+5.59% | 17.89B | |
-12.58% | 16.58B | |
+3.45% | 15.73B | |
+78.67% | 13.01B | |
+79.99% | 12.92B | |
+37.46% | 12.57B |
- Stock Market
- Equities
- GEMA Stock
- Financials International Medical Center of Biomaterials Processing and Cryostorage Public